Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2012
08/16/2012WO2012108747A2 Composition and cosmetic composition for treating brain cancer comprising helena root extract
08/16/2012WO2012108746A2 Composition and cosmetic composition for treating brain cancer comprising rubia cordifolia root extract
08/16/2012WO2012108745A2 Composition and health functional food for treating brain cancer comprising gleditsiae semen extract
08/16/2012WO2012108744A2 Composition and health functional food for treating brain cancer comprising inula flower extract
08/16/2012WO2012108743A2 Composition and cosmetic composition for treating brain cancer comprising white pharbitis seed extract
08/16/2012WO2012108742A2 Composition and health functional food for treating brain cancer comprising tussilago farfara l. flower extract
08/16/2012WO2012108586A1 Method for producing lymphocytes including activated natural killer cells, and pharmaceutical composition including same
08/16/2012WO2012108478A1 Monocyclic compound
08/16/2012WO2012108397A1 Novel lipid
08/16/2012WO2012108297A1 AQUEOUS SOLUTION CONTAINING PARTIAL RaS POLYPEPTIDE AND METHOD FOR SCREENING INHIBITOR OF RaS FUNCTION
08/16/2012WO2012107592A1 Hexapeptide with improved activity in the repair of cellular dna of dermal cells
08/16/2012WO2012107589A1 Methods and pharmaceutical compositions for the treatment and prevention of hcv infections
08/16/2012WO2012107531A1 B-type plexin antagonists and uses thereof
08/16/2012WO2012107500A1 [1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
08/16/2012WO2012107499A1 Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disorders
08/16/2012WO2012107498A1 Lysine demethylase inhibitors for myeloproliferative disorders
08/16/2012WO2012107424A1 Anti-gb3 antibodies useful in treating disorders associated with angiogenesis
08/16/2012WO2012107416A2 Improved immunotherapy
08/16/2012WO2012107304A1 Histone deacetylase (hdac) inhibiting compounds and method of making same
08/16/2012WO2012107262A1 Dihydrobenzopyran, thiochroman, tetrahydroquinoleine and tetrahydronaphtalene derivatives and their use in anticancer therapy
08/16/2012WO2012107153A1 Amino statin derivativesfor the treatment of arthrosis
08/16/2012WO2012106947A1 Medicine composition containing vitamin d and metformin
08/16/2012WO2012106812A1 A method of treating cancer
08/16/2012WO2012088266A3 Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
08/16/2012WO2012087943A3 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
08/16/2012WO2012087017A3 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and method for preparing same
08/16/2012WO2012084993A3 Biologically active oligonucleotides capable of modulating the immune system i
08/16/2012WO2012078746A9 Compositions and methods for mobilizing stem cells
08/16/2012WO2012078667A9 Compositions and methods relating to proliferative diseases
08/16/2012WO2012076756A3 Pharmaceutical compositions comprising 8-substituted dibenzylbutyrolactone lignans
08/16/2012WO2012075383A3 Bromodomain inhibitors and uses thereof
08/16/2012WO2012075211A3 Combination therapy with a gallium complex
08/16/2012WO2012071554A3 Anti-il-6 antibodies for the treatment of oral mucositis
08/16/2012WO2012071414A3 Quinoxaline compounds and uses thereof
08/16/2012WO2012071411A3 Nk cell modulating treatments and methods for treatment of hematological malignancies
08/16/2012WO2012068106A3 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
08/16/2012WO2012061413A3 Isoflavonoid compositions and methods for the treatment of cancer
08/16/2012WO2012061342A3 Substituted benzo-imidazo-pyrido-diazepine compounds
08/16/2012WO2012037380A3 Formulations of guanylate cyclase c agonists and methods of use
08/16/2012WO2012031603A3 Airway administration of angiogenesis inhibitors
08/16/2012WO2011159928A3 Anti-dr4 agonist antibodies
08/16/2012WO2011092469A8 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
08/16/2012WO2011091716A9 Epidermal growth factor receptor variant
08/16/2012US20120209050 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/16/2012US20120209012 Compounds, compositions and methods
08/16/2012US20120208889 Class- and isoform-specific hdac inhibitors and uses thereof
08/16/2012US20120208884 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/16/2012US20120208883 Treatment of oncological diseases
08/16/2012US20120208873 Tea polyphenols products for ceasing smoking and treating and/or preventing nicotine or nicotine-derived compounds or estrogen induced breast cancer
08/16/2012US20120208872 Use of tea polyphenols for treating and/or preventing nicotine or nicotine-derived compounds or estrogen induced breast cancer
08/16/2012US20120208871 Use of toll-like receptor and agonist for treating cancer
08/16/2012US20120208867 Hmgb1 binding nucleic acid molecule and applications thereof
08/16/2012US20120208859 Novel mek inhibitors useful in the treatment of diseases
08/16/2012US20120208855 Amino-benzoic acid derivatives for use in the treatment of dihydrogenase-related disorders
08/16/2012US20120208844 Substituted piperidines that increase p53 activity and the uses thereof
08/16/2012US20120208841 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
08/16/2012US20120208837 Substituted azaindoles
08/16/2012US20120208833 4-(Substituted Anilino)-Quinazoline Derivatives Useful as Tyrosine Kinase Inhibitors
08/16/2012US20120208828 Azole Derivatives as WTN Pathway Inhibitors
08/16/2012US20120208827 Benzimidazoles as fatty acid synthase inhibitors
08/16/2012US20120208826 Heterocyclic amide compounds as protein kinase inhibitors
08/16/2012US20120208825 Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
08/16/2012US20120208824 ROS Kinase in Lung Cancer
08/16/2012US20120208819 Heterocyclic compounds useful as pdk1 inhibitors
08/16/2012US20120208815 Pim kinase inhibitors and methods of their use
08/16/2012US20120208814 Thetrahydroquinolines Derivatives As Bromodomain Inhibitors
08/16/2012US20120208811 Aminopyrazole Derivative
08/16/2012US20120208810 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
08/16/2012US20120208809 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
08/16/2012US20120208808 Pyrazolopyrimidine derivatives
08/16/2012US20120208806 Hsp90 Inhibitors
08/16/2012US20120208805 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
08/16/2012US20120208801 Aminodiazepines as Toll-Like Receptor Modulators
08/16/2012US20120208799 Compounds
08/16/2012US20120208798 Tetrahydroquinoline Derivatives And Their Pharmaceutical Use
08/16/2012US20120208797 Pyrimidone derivatives
08/16/2012US20120208794 Fused heterocyclic ring derivative and use thereof
08/16/2012US20120208792 Protein kinase modulators
08/16/2012US20120208791 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
08/16/2012US20120208780 Hybrid nanomaterials consisting of pseudorotaxanes, pseudopolyrotaxanes, rotaxanes, polyrotaxanes, nanoparticles and quantum dots
08/16/2012US20120208776 Anti-neoplastic compositions comprising extracts of black cohosh
08/16/2012US20120208774 Method for inhibiting "melanoma inhibitory activity" mia
08/16/2012US20120208770 Carcinoma Homing Peptide (CHP), Its Analogs, and Methods of Using
08/16/2012US20120208769 Chemokine-Mucin Fusions Linked to Glycosylphosphatidylinositol (GPI)-Anchors in Tissue Regeneration and as Tumour Immune Adjuvants
08/16/2012US20120208768 Specific binding sites in collagen for integrins and use thereof
08/16/2012US20120208755 Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
08/16/2012US20120208752 Cell proliferation-promoting peptide and use thereof
08/16/2012US20120208751 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations
08/16/2012US20120208742 Compositions of a peptide targeting system for treating cancer
08/16/2012US20120208260 Novel lactobacillus plantarum and composition comprising the same
08/16/2012US20120207857 Compositions and Methods for Potentiation of Cancer Agents
08/16/2012US20120207856 MSH3 Expression Status Determines the Responsiveness of Cancer Cells to the Chemotherapeutic Treatment with PARP Inhibitors and Platinum Drugs
08/16/2012US20120207855 Cephalotaxine alkaloid compositions and uses thereof
08/16/2012US20120207849 Amniotic Membrane Preparations and Purified Compositions and Anti-Angiogenesis Treatment
08/16/2012US20120207818 Composition for suppressing expression of target gene
08/16/2012US20120207817 Small interfering rnas and methods for prevention, inhibition and/or treatment of malignant progression of breast cancer
08/16/2012US20120207809 Method and system for effecting changes in pigmented tissue
08/16/2012US20120207796 Polymeric drug delivery compositions and methods for treating ophthalmic diseases
08/16/2012US20120207795 Cationic polymer coated mesoporous silica nanoparticles and uses thereof
08/16/2012US20120207775 Immunogenic Epitopes as Targets for Universal Cancer Vaccines
1 ... 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 ... 2211